William F. Huffman

Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents

David Payne, William H. Miller, Valerie Berry et al. · Antimicrobial Agents and Chemotherapy · 2002 · 165 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK

Mark A. Seefeld, William H. Miller, Kenneth A. Newlander et al. · Journal of Medicinal Chemistry · 2003 · 161 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Peptide substrates and inhibitors of the HIV-1 protease

Michael L. Moore, William M. Bryan, Stephen A. Fakhoury et al. · Biochemical and Biophysical Research Communications · 1989 · 161 citations

Life Sciences, Biochemistry, Molecular Biology +14

1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)

Dirk A. Heerding, George Chan, Walter E. DeWolf et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 124 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic

William H. Miller, Doreen Alberts, Pradip K. Bhatnagar et al. · Journal of Medicinal Chemistry · 1999 · 117 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7